Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Abbott; Bayer AG; Merck/Schering Plough; Roche
- Consultant Fee/Honoraria/Speaker's Bureau - Natera; Merck/Schering Plough; Ortho Clinical Diagnostics; Tosoh Bioscience
- Equity/Stock(s)/Options - Procyrion